MONITORAGGIO PLASMATICO DELLA L-DOPA: UTILIZZO CLINICO IN PAZIENTI PARKINSONIANI

Translated title of the contribution: Plasmatic L-DOPA monitoring: Clinical use in Parkinson disease

G. P. Nordera, A. Monge, L. Barbato, A. Bolner, R. Bogoni, G. Neri, F. Stocchi

Research output: Contribution to journalArticlepeer-review

Abstract

In Parkinson's disease Long Treatment Syndrome (LTS) is a frequent and unpleasant feature of treatment with L-DOPA for long periods. In order to achieve the best effectiveness of treatment, different preparations of the drugs have been introduced: controlled release (CR), liquid rapidly-absorbed formulas. Therefore plasmatic L-DOPA monitoring represents an important tool in order to study and improve therapeutical strategies. 100 patients with Parkinson's Disease treated with L-DOPA underwent plasmatic drug monitoring and the authors underline the importance of this procedure in the choice of individualized therapeutic schemata.

Translated title of the contributionPlasmatic L-DOPA monitoring: Clinical use in Parkinson disease
Original languageItalian
Pages (from-to)753-757
Number of pages5
JournalRivista di Neurobiologia
Volume41
Issue number5
Publication statusPublished - 1995

ASJC Scopus subject areas

  • Neuroscience(all)

Fingerprint

Dive into the research topics of 'Plasmatic L-DOPA monitoring: Clinical use in Parkinson disease'. Together they form a unique fingerprint.

Cite this